- Home
- ACIU vs SMTI Comparison
ACIU vs SMTI Comparison
Compare ACIU & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SMTI
- Stock Information
- Founded
- ACIU 2003
- SMTI 1982
- Country
- ACIU Switzerland
- SMTI United States
- Employees
- ACIU N/A
- SMTI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ACIU Health Care
- SMTI Health Care
- Exchange
- ACIU Nasdaq
- SMTI Nasdaq
- Market Cap
- ACIU 332.4M
- SMTI 288.2M
- IPO Year
- ACIU 2016
- SMTI N/A
- Fundamental
- Price
- ACIU $3.15
- SMTI $36.64
- Analyst Decision
- ACIU Strong Buy
- SMTI Buy
- Analyst Count
- ACIU 2
- SMTI 1
- Target Price
- ACIU $12.00
- SMTI $44.00
- AVG Volume (30 Days)
- ACIU 153.3K
- SMTI 35.0K
- Earning Date
- ACIU 11-05-2024
- SMTI 11-12-2024
- Dividend Yield
- ACIU N/A
- SMTI N/A
- EPS Growth
- ACIU N/A
- SMTI N/A
- EPS
- ACIU N/A
- SMTI N/A
- Revenue
- ACIU $48,505,404.00
- SMTI $78,056,873.00
- Revenue This Year
- ACIU $85.33
- SMTI $29.95
- Revenue Next Year
- ACIU $80.69
- SMTI $19.68
- P/E Ratio
- ACIU N/A
- SMTI N/A
- Revenue Growth
- ACIU 4097200.00
- SMTI 24.66
- 52 Week Low
- ACIU $2.25
- SMTI $26.00
- 52 Week High
- ACIU $5.14
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- SMTI 56.60
- Support Level
- ACIU $3.10
- SMTI $34.50
- Resistance Level
- ACIU $3.25
- SMTI $37.60
- Average True Range (ATR)
- ACIU 0.14
- SMTI 1.88
- MACD
- ACIU -0.02
- SMTI -0.23
- Stochastic Oscillator
- ACIU 13.16
- SMTI 59.81
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.